- 专利标题： Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
-
申请号： US11076395申请日： 2005-10-20
-
公开(公告)号： US20060029594A1公开(公告)日： 2006-02-09
- 发明人: Robert Ames , Edward Appelbaum , Irwin Chaiken , Richard Cook , Mitchell Gross , Stephen Holmes , Lynette McMillan , Timothy Theisen
- 申请人： Robert Ames , Edward Appelbaum , Irwin Chaiken , Richard Cook , Mitchell Gross , Stephen Holmes , Lynette McMillan , Timothy Theisen
- 专利权人： SmithKline Beecham Corporation,SmithKline Beecham p.l.c.
- 当前专利权人： SmithKline Beecham Corporation,SmithKline Beecham p.l.c.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C12N5/06 ; C07K16/44
摘要：
Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.
公开/授权文献
信息查询
